Members can now access the re-tendered Antibodies & Sera and other matrices (LAB4042) framework agreement – the only higher-education focused antibodies agreement available to universities. This framework is live from the 1st of July 2021.
What’s New?
• This iteration of the framework features two new suppliers: Enzo and Cambridge BioScience.
• Members can use a revised further competition option for the procurement of sera (lot 2).
By using the agreement, members will benefit from:
• Fixed commercial terms on all lots.
• An easy and compliant route to market for participating Institutions.
• Increased customer choice through a high number of participating suppliers. • Additional discounts and institution/project-specific service requirements can be requested via the further competition call off method.
• Annual lot rankings refreshed to improve competitive pricing.
• Robust framework management process in place.
Awarded Suppliers:
The following suppliers have been awarded to the agreement under two lots:
Lot 1 – Antibodies
- Stratech
- Antibodies.com
- Biotechne Ltd
- BioServ UK Ltd
- Proteintech
- Fisher Scientific UK Ltd
- Miltenyi Biotec Ltd
- 2B Scientific Ltd
- Merck Life Science UK Limited
- Cambridge BioScience
- Cell Signalling Technology Europe B.V
- Enzo Life Sciences
- Oxford Biosystems
- Biolegend
- Insight Biotechnology
- Generon Ltd
- Takara
- Agilent Technologies LDA UK Limited
Lot 2 - Sera and other matrices
- BioServ UK
- Stratech
- Antibodies.com
- 2B Scientific Ltd
- Fisher Scientific
- Merck
- Takara
- Agilent Technologies LDA UK Limited
SUPC Category Manager for STEMed Dani Sweeney says “This framework will help universities conducting vital research to procure their supplies in a cost-effective and compliant way. As the only higher education-focused agreement for antibodies, this procurement solution meets an essential need and we’re confident will provide excellent value to the sector.”
The agreement went live on the 1st of July 2021 and will run for 30 months with an optional 6-month extension. This agreement is planned to run coterminous with the NEUPC Life Science Reagents agreement as they will be a combined framework for any new versions.
Have a look at this interactive presentation which explains how to use the framework. Please use the arrow keys to move through to the next section or click directly on the required section of the video.
Further information including contact details, service offering and achieved scores is provided in the Buyers Guide available on HE Contracts.
Please contact Antonio Ramirez if you need any assistance with this agreement.